With Nathan Beaver, Benjamin Berkowitz, George Best, Courtenay Brinckerhoff, Jeanne Gills, Stephen Maebius
In two decisions issued May 10, 2010, the Federal Circuit clarified the rights of patentees to receive patent term extension (PTE) based on FDA approval of a new drug product.